Cancel
See Linkedin
Known information
- Is a fourth-year student at New York University studying Biomolecular Science with a minor in Public Health
- First performed research focused on using protein engineering to develop theranostics for glioblastoma
- Was involved in a US Department of Energy research project focusing on developing and testing CRISPR interference systems in bacteria
- Has been involved in epidemiological research focusing on the impacts of COVID-19 on marginalized populations in New York City, presenting findings at the American Public Health Association National Conference
- Has interests in exploring drug design and genetic therapies
- Has a strong passion for making disease treatment accessible
About Nephrogen
Nephrogen is a healthcare company focused on developing curative gene therapies for kidney diseases, particularly polycystic kidney disease (PKD), using advanced CRISPR-Cas genome editing and novel adeno-associated viruses.
Report inaccurate information